Final height of growth hormone-treated patients with growth hormone deficiency: the North American experience

The results of treatment of growth hormone (GH)-deficient patients with rec ombinant Gr I are better than the results of treatment with pituitary GH. T he reasons fur this improvement include higher dosages, more consistent tre atment, and daily administration. Under ideal circumstances, final height i n patients with GH deficiency (GHD) can be within the normal range for adul t height with GH treatment, and brought close to their target height. To ac hieve this result, it is important to diagnose and treat GHD early, use ade quate doses of GH, and continue treatment until final height.